152 related articles for article (PubMed ID: 1929259)
21. Single-dose pharmacokinetics and metabolism of [14C]remofovir in rats and cynomolgus monkeys.
Lin CC; Xu C; Zhu N; Lourenco D; Yeh LT
Antimicrob Agents Chemother; 2005 Mar; 49(3):925-30. PubMed ID: 15728885
[TBL] [Abstract][Full Text] [Related]
22. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
23. Transport of the anti-varicella-zoster virus agent 6-methoxypurine arabinoside and its 2'-O-valerate prodrug into human erythrocytes.
Prus KL; Heidenreich AC; Zimmerman TP
Antimicrob Agents Chemother; 1992 Feb; 36(2):283-6. PubMed ID: 1318676
[TBL] [Abstract][Full Text] [Related]
24. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and disposition of CS-0777, a sphingosine 1-phosphate receptor modulator, in rats and monkeys.
Inaba S; Ikeda T; Goto M; Tanaka H; Takahashi M; Iwabuchi H; Izumi T
Xenobiotica; 2015; 45(12):1063-80. PubMed ID: 26084376
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
28. Species differences in the formation of vabicaserin carbamoyl glucuronide.
Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
[TBL] [Abstract][Full Text] [Related]
29. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
30. Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats.
Brunner V; Maynadier B; Chen L; Roques L; Hude I; Séguier S; Barthe L; Hermann P
Drug Des Devel Ther; 2015; 9():3199-215. PubMed ID: 26150694
[TBL] [Abstract][Full Text] [Related]
31. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and metabolism of KW-4490, a selective phosphodiesterase 4 inhibitor: difference in excretion of KW-4490 and acylglucuronide metabolites between rats and cynomolgus monkeys.
Fujita K; Kodaira H; Kuwabara T; Kobayashi H
Xenobiotica; 2008 May; 38(5):511-26. PubMed ID: 18421624
[TBL] [Abstract][Full Text] [Related]
33. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K
Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385
[TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and metabolism of [(14)C]ribavirin in rats and cynomolgus monkeys.
Lin CC; Yeh LT; Luu T; Lourenco D; Lau JY
Antimicrob Agents Chemother; 2003 Apr; 47(4):1395-8. PubMed ID: 12654676
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
Teng R; Girard D; Gootz TD; Foulds G; Liston TE
Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
[TBL] [Abstract][Full Text] [Related]
38. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.
Tanaka Y; Sekiguchi M; Sawamoto T; Hata T; Esumi Y; Sugai S; Ninomiya S
Eur J Drug Metab Pharmacokinet; 1994; 19(1):47-58. PubMed ID: 7957452
[TBL] [Abstract][Full Text] [Related]
40. Absorption, pharmacokinetics and excretion of levovirin in rats, dogs and cynomolgus monkeys.
Lin CC; Luu T; Lourenco D; Yeh LT; Lau JY
J Antimicrob Chemother; 2003 Jan; 51(1):93-9. PubMed ID: 12493792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
